Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Therapeutic vaccination against chronic hepatitis C virus infection.

Ip PP, Nijman HW, Wilschut J, Daemen T.

Antiviral Res. 2012 Oct;96(1):36-50. doi: 10.1016/j.antiviral.2012.07.006. Epub 2012 Jul 25. Review.

PMID:
22841700
2.

Treatment of chronic hepatitis C in Asia: when East meets West.

Yu ML, Chuang WL.

J Gastroenterol Hepatol. 2009 Mar;24(3):336-45. doi: 10.1111/j.1440-1746.2009.05789.x. Review.

PMID:
19335784
3.

Therapeutic vaccines against hepatitis C virus.

Xue J, Zhu H, Chen Z.

Infect Genet Evol. 2014 Mar;22:120-9. doi: 10.1016/j.meegid.2014.01.008. Epub 2014 Jan 23. Review.

PMID:
24462908
4.

Telaprevir: a hepatitis C NS3/4A protease inhibitor.

Matthews SJ, Lancaster JW.

Clin Ther. 2012 Sep;34(9):1857-82. doi: 10.1016/j.clinthera.2012.07.011. Epub 2012 Aug 28. Review.

PMID:
22951253
5.

Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice.

Cao J, Chen Z, Ren Y, Luo Y, Cao M, Lu W, Zhao P, Qi Z.

Vaccine. 2011 May 9;29(20):3714-23. doi: 10.1016/j.vaccine.2011.02.083. Epub 2011 Mar 9.

PMID:
21396407
6.

Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.

Klade CS, Wedemeyer H, Berg T, Hinrichsen H, Cholewinska G, Zeuzem S, Blum H, Buschle M, Jelovcan S, Buerger V, Tauber E, Frisch J, Manns MP.

Gastroenterology. 2008 May;134(5):1385-95. doi: 10.1053/j.gastro.2008.02.058. Epub 2008 Mar 4.

PMID:
18471515
7.

Pathogenesis, diagnosis and management of hepatitis C.

Boyer N, Marcellin P.

J Hepatol. 2000;32(1 Suppl):98-112. Review.

PMID:
10728798
8.

Management issues in chronic viral hepatitis: hepatitis C.

Sievert W.

J Gastroenterol Hepatol. 2002 Apr;17(4):415-22. Review.

PMID:
11982722
9.

[Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver].

Zuckerman E, Safadi R, Oren R, Shibolet O, Baruch Y, Bruck R, Lurei Y, Kaspa RT, Abu-Mouch S, Shouval D, Ben-Ari Z; Israeli Association for the Study of the Liver..

Harefuah. 2012 Dec;151(12):709-14, 719. Hebrew.

PMID:
23330266
10.

Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.

Torresi J, Johnson D, Wedemeyer H.

J Hepatol. 2011 Jun;54(6):1273-85. doi: 10.1016/j.jhep.2010.09.040. Epub 2011 Jan 12. Review.

11.

Development of a heterologous, multigenotype vaccine against hepatitis C virus infection.

Encke J, Radunz W, Eisenbach C, Geib J, Gehrke S, Pfaff E, Stremmel W.

Eur J Clin Invest. 2007 May;37(5):396-406.

PMID:
17461986
12.

Viral hepatitis.

Trépo C, Zoulim F, Pradat P.

Curr Opin Infect Dis. 1999 Oct;12(5):481-90.

PMID:
17035815
13.

[Chronic hepatitis C].

Grammatikos G, Sarrazin C.

Dtsch Med Wochenschr. 2010 Dec;135(50):2525-34; quiz 2535-8. doi: 10.1055/s-0030-1269423. Epub 2010 Dec 7. Review. German.

PMID:
21140330
14.

[Antiviral treatment of chronic hepatitis C].

Berger A.

Med Monatsschr Pharm. 2012 Feb;35(2):55-60. Review. German.

PMID:
22400430
15.

Hepatitis C virus infection management in 2012.

Van Gulick JJ, Lamers MH, Drenth JP.

Panminerva Med. 2012 Mar;54(1):1-9. Review.

PMID:
22278112
16.

Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity.

Zhang P, Zhong L, Struble EB, Watanabe H, Kachko A, Mihalik K, Virata-Theimer ML, Alter HJ, Feinstone S, Major M.

Proc Natl Acad Sci U S A. 2009 May 5;106(18):7537-41. doi: 10.1073/pnas.0902749106. Epub 2009 Apr 20.

17.

Ribavirin in the treatment of hepatitis C.

Abonyi ME, Lakatos PL.

Anticancer Res. 2005 Mar-Apr;25(2B):1315-20.

18.

Immune-based therapy for chronic hepatitis C.

Chang DY, Shin EC.

J Leukoc Biol. 2009 Jul;86(1):33-9. doi: 10.1189/jlb.1208772. Epub 2009 Apr 24.

PMID:
19395471
19.

New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives.

Welsch C, Jesudian A, Zeuzem S, Jacobson I.

Gut. 2012 May;61 Suppl 1:i36-46. doi: 10.1136/gutjnl-2012-302144. Review. Erratum in: Gut. 2012 Aug;61(8):1145.

PMID:
22504918
20.

[Direct antiviral treatment strategies in chronic hepatitis C].

Neumann-Haefelin C, Blum HE, Thimme R.

Dtsch Med Wochenschr. 2012 Jun;137(25-26):1360-5. doi: 10.1055/s-0032-1305064. Epub 2012 May 31. Review. German.

PMID:
22653493

Supplemental Content

Support Center